164 related articles for article (PubMed ID: 30826602)
1. Circulating levels of CXCL11 and CXCL12 are biomarkers of cirrhosis in patients with chronic hepatitis C infection.
Chalin A; Lefevre B; Devisme C; Barget N; Amiot L; Samson M
Cytokine; 2019 May; 117():72-78. PubMed ID: 30826602
[TBL] [Abstract][Full Text] [Related]
2. Serum CXCL10, CXCL11, CXCL12, and CXCL14 chemokine patterns in patients with acute liver injury.
Chalin A; Lefevre B; Devisme C; Pronier C; Carrière V; Thibault V; Amiot L; Samson M
Cytokine; 2018 Nov; 111():500-504. PubMed ID: 29880273
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of CXCL10, CXCL11, CXCL12 and CXCL13 chemokines in serum and cerebrospinal fluid in patients with tick borne encephalitis (TBE).
Zajkowska J; Moniuszko-Malinowska A; Pancewicz SA; Muszyńska-Mazur A; Kondrusik M; Grygorczuk S; Swierzbińska-Pijanowska R; Dunaj J; Czupryna P
Adv Med Sci; 2011; 56(2):311-7. PubMed ID: 22008312
[TBL] [Abstract][Full Text] [Related]
4. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
[TBL] [Abstract][Full Text] [Related]
5. [THE ROLE OF CYTOKINES AND CHEMOKINES IN LABORATORY DIAGNOSTIC OF CHRONIC VIRAL HEPATITIS C].
Semenov AV; Arsentieva NA; Lubimova NE; Tulienev SV; Basina VV; Esaulenko EV; Totolyan AA
Klin Lab Diagn; 2015 Aug; 60(8):45-51. PubMed ID: 26596048
[TBL] [Abstract][Full Text] [Related]
6. Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection.
Zeremski M; Dimova R; Brown Q; Jacobson IM; Markatou M; Talal AH
J Infect Dis; 2009 Dec; 200(11):1774-80. PubMed ID: 19848607
[TBL] [Abstract][Full Text] [Related]
7. Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis.
Antonelli A; Fallahi P; Ferrari SM; Sebastiani M; Manfredi A; Mazzi V; Fabiani S; Centanni M; Marchi S; Ferri C
Mod Rheumatol; 2012 Sep; 22(5):659-67. PubMed ID: 22160826
[TBL] [Abstract][Full Text] [Related]
8. Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C.
Zeremski M; Petrovic LM; Chiriboga L; Brown QB; Yee HT; Kinkhabwala M; Jacobson IM; Dimova R; Markatou M; Talal AH
Hepatology; 2008 Nov; 48(5):1440-50. PubMed ID: 18798334
[TBL] [Abstract][Full Text] [Related]
9. Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection.
Berres ML; Trautwein C; Schmeding M; Eurich D; Tacke F; Bahra M; Neuhaus P; Neumann UP; Wasmuth HE
Hepatology; 2011 Feb; 53(2):596-603. PubMed ID: 21274880
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of CXCL8, CXCL10, CXCL11, CXCL12 and CXCL13 in serum and cerebrospinal fluid of patients with neuroborreliosis.
Moniuszko A; Czupryna P; Pancewicz S; Rutkowski K; Zajkowska O; Swierzbińska R; Grygorczuk S; Kondrusik M; Owłasiuk P; Zajkowska J
Immunol Lett; 2014; 157(1-2):45-50. PubMed ID: 24239846
[TBL] [Abstract][Full Text] [Related]
11. The combination of CXCL9, CXCL10 and CXCL11 levels during primary HIV infection predicts HIV disease progression.
Yin X; Wang Z; Wu T; Ma M; Zhang Z; Chu Z; Hu Q; Ding H; Han X; Xu J; Shang H; Jiang Y
J Transl Med; 2019 Dec; 17(1):417. PubMed ID: 31836011
[TBL] [Abstract][Full Text] [Related]
12. CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases-associated interstitial lung disease and interstitial pneumonia with autoimmune features.
Kameda M; Otsuka M; Chiba H; Kuronuma K; Hasegawa T; Takahashi H; Takahashi H
PLoS One; 2020; 15(11):e0241719. PubMed ID: 33137121
[TBL] [Abstract][Full Text] [Related]
13. Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2.
Antonelli A; Fallahi P; Ferrari SM; Corrado A; Sebastiani M; Giuggioli D; Miccoli M; Zignego AL; Sansonno D; Marchi S; Ferri C
Clin Rheumatol; 2013 Aug; 32(8):1147-54. PubMed ID: 23559389
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro.
Helbig KJ; Ruszkiewicz A; Lanford RE; Berzsenyi MD; Harley HA; McColl SR; Beard MR
J Virol; 2009 Jan; 83(2):836-46. PubMed ID: 18987152
[TBL] [Abstract][Full Text] [Related]
15. Study of CXCL9-11 gene polymorphisms in liver fibrosis among patients with chronic hepatitis C.
Magri MC; Alvarez MSM; Iogi AA; Alves GM; Manchiero C; Dantas BP; Prata TVG; Nunes AKDS; Tengan FM
Pathog Dis; 2021 Mar; 79(3):. PubMed ID: 33476381
[TBL] [Abstract][Full Text] [Related]
16. IP-10 can be measured in dried plasma spots in patients with chronic hepatitis C infection.
Ruhwald M; Andersen ES; Christensen PB; Moessner BK; Weis N
PLoS One; 2012; 7(9):e45181. PubMed ID: 23024806
[TBL] [Abstract][Full Text] [Related]
17. CXCL9 and CXCL10 chemokines as predictors of liver fibrosis in a cohort of primarily African-American injection drug users with chronic hepatitis C.
Zeremski M; Dimova R; Astemborski J; Thomas DL; Talal AH
J Infect Dis; 2011 Sep; 204(6):832-6. PubMed ID: 21849280
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of angiostatic chemokines IP-10/CXCL10 and I-TAC/CXCL11 in human obesity and their implication for adipose tissue angiogenesis.
Hueso L; Ortega R; Selles F; Wu-Xiong NY; Ortega J; Civera M; Ascaso JF; Sanz MJ; Real JT; Piqueras L
Int J Obes (Lond); 2018 Aug; 42(8):1406-1417. PubMed ID: 29795466
[TBL] [Abstract][Full Text] [Related]
19. Antiviral treatment significantly reduces the levels of CXCL9, CXCL10 and CXCL11 in chronic hepatitis C.
Radmanić L; Šimičić P; Bodulić K; Vince A; Zidovec-Lepej S
Cytokine; 2024 Apr; 176():156529. PubMed ID: 38335772
[TBL] [Abstract][Full Text] [Related]
20. A correlation study between gene polymorphism of Th cell expressed chemokine receptor CXCR3 and its ligand levels with HCV infection prognosis.
Lu Y; Lin LY; Tan JG; Deng HP; Li XH; Zhang Z; Li Y; Zhou Z; Xu X; Xie X; Mei SJ
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1290-1295. PubMed ID: 28387899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]